摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-bromo-2-(4'-hydroxyphenyl)imidazo[1,2-a]pyridine | 956500-18-8

中文名称
——
中文别名
——
英文名称
8-bromo-2-(4'-hydroxyphenyl)imidazo[1,2-a]pyridine
英文别名
4-(8-bromoimidazo[1,2-a]pyridin-2-yl)phenol
8-bromo-2-(4'-hydroxyphenyl)imidazo[1,2-a]pyridine化学式
CAS
956500-18-8
化学式
C13H9BrN2O
mdl
——
分子量
289.131
InChiKey
RAQFZCMVVMGRPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    37.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    8-bromo-2-(4'-hydroxyphenyl)imidazo[1,2-a]pyridine吡啶(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichlorideN-溴代丁二酰亚胺(NBS)四(三苯基膦)钯三乙醇胺potassium acetatepotassium carbonate三氯氧磷 作用下, 以 四氢呋喃1,4-二氧六环乙醇二氯甲烷硝基苯甲苯乙腈 为溶剂, 反应 31.0h, 生成 15-[4-(2,6-Diphenylpyrimidin-4-yl)phenyl]-9,14-diphenyl-8,13,16-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2,4,6,8,11,14,16-octaene
    参考文献:
    名称:
    헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
    摘要:
    本说明书涉及标记为化学式1的杂环化合物及其包含的有机发光器件。
    公开号:
    KR102089307B1
  • 作为产物:
    描述:
    2-氨基-3-溴吡啶2-溴-4'-羟基苯乙酮乙腈碳酸氢钠 作用下, 以 乙腈 为溶剂, 反应 6.08h, 以to obtain 368 mg (corresponding to 1.27 mmol) of 8-bromo-2-(4′-hydroxyphenyl)imidazo[1,2-a]pyridine (FIG. 13, Step 2)的产率得到8-bromo-2-(4'-hydroxyphenyl)imidazo[1,2-a]pyridine
    参考文献:
    名称:
    USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME
    摘要:
    本发明提供了一种检测生物组织中淀粉样物质的试剂,该试剂使用与淀粉样物质亲和力强且毒性低(如突变原性)的化合物,可以高灵敏度地在体内外检测淀粉样物质。检测生物组织中沉积的淀粉样物质的试剂包括下式(1)所表示的化合物或其盐:其中,A1、A2、A3和A4独立表示碳或氮,R3是下式所表示的基团:其中,R1是放射性卤素取代基;m为0到4的整数;n为0或1的整数,但至少有一个A1、A2、A3和A4表示碳,并且R3与A1、A2、A3或A4表示的碳结合。
    公开号:
    US20100249408A1
点击查看最新优质反应信息

文献信息

  • Novel Compound Having Affinity to Amyloid
    申请人:Tanifuji Shigeyuki
    公开号:US20100249407A1
    公开(公告)日:2010-09-30
    The invention relates to a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagenicity, and also relates to a low-toxic diagnostic agent for Alzheimer's disease containing the compound. The compound is represented by the following formula (1) or a salt thereof: wherein A 1 , A 2 , A 3 and A 4 independently represent a carbon or a nitrogen, and R 3 is a group represented by the following formula: wherein R 1 is a radioactive halogen substituent; m is an integer of 0 to 4; and n is an integer of 0 or 1, provided that at least one of A 1 , A 2 , A 3 and A 4 represents a carbon, and R 3 binds to a carbon represented by A 1 , A 2 , A 3 or A 4 .
    本发明涉及一种与淀粉样物质亲和力强、从正常组织中清除速度足够快且毒性被抑制(例如突变原性),以及一种含有该化合物的低毒性诊断剂,用于阿尔茨海默病。该化合物由以下式(1)或其盐表示:其中,A1、A2、A3和A4独立地表示碳或氮,R3是由以下式表示的基团:其中,R1是放射性卤素取代基;m是0至4的整数;n是0或1的整数,但至少有一个A1、A2、A3和A4表示碳,且R3与A1、A2、A3或A4表示的碳结合。
  • Compound having affinity to amyloid
    申请人:Nihon Medi-Physics Co., Ltd.
    公开号:US08022207B2
    公开(公告)日:2011-09-20
    The invention relates to a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagenicity, and also relates to a low-toxic diagnostic agent for Alzheimer's disease containing the compound. The compound is represented by the following formula (1) or a salt thereof: wherein A1, A2, A3 and A4 independently represent a carbon or a nitrogen, and R3 is a group represented by the following formula: wherein R1 is a radioactive halogen substituent; m is an integer of 0 to 4; and n is an integer of 0 or 1, provided that at least one of A1, A2, A3 and A4 represents a carbon, and R3 binds to a carbon represented by A1, A2, A3 or A4.
    本发明涉及一种具有与淀粉样物质亲和力、从正常组织中快速清除并且毒性被抑制,如致突变性的化合物,以及一种含有该化合物的低毒性阿尔茨海默病诊断剂。该化合物由以下式(1)或其盐表示:其中A1、A2、A3和A4独立地代表碳或氮,R3是由以下式表示的基团:其中R1是放射性卤素取代基;m为0到4的整数;n为0或1的整数,但至少有一个A1、A2、A3和A4代表碳,并且R3结合到由A1、A2、A3或A4表示的碳上。
  • NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID
    申请人:NIHON MEDI-PHYSICS CO., LTD.
    公开号:EP2098522A1
    公开(公告)日:2009-09-09
    It is intended to provide a compound that is useful as a probe targeting amyloid for imaging diagnosis and a diagnostic agent for Alzheimer's disease comprising the compound. Provided are a compound represented by the following formula (1): (wherein A1, A2, A3 and A4 independently represents a carbon or nitrogen, R1 is a radioactive halogen substituent, R2 is a group selected from the group consisting of hydrogen, hydroxyl group, methoxy group, carboxyl group, amino group, N-methylamino group, N, N-dimethy-lamino group and cyano group, p is an integer of 0 to 2, and provided that at least one of A1, A2, A3 and A4 represents a carbon, and R1 binds to a carbon represented by A1, A2, A3 or A4), or a salt thereof, and a diagnostic agent for Alzheimer's disease comprising a compound represented by the above formula or a salt thereof.
    本发明旨在提供一种可作为淀粉样蛋白靶向探针用于成像诊断的化合物,以及一种包含该化合物的阿尔茨海默病诊断剂。本发明提供了由下式(1)代表的化合物: (其中 A1、A2、A3 和 A4 独立地代表碳或氮、 R1 是放射性卤素取代基、 R2 是选自氢、羟基、甲氧基、羧基、基、N-甲基基、N,N-二甲基基和基的基团、 p 为 0 至 2 的整数,且 条件是 A1、A2、A3 和 A4 中至少有一个代表碳,且 R1 与 A1、A2、A3 或 A4 所代表的碳结合)、 或其盐,以及由上式所代表的化合物或其盐组成的阿尔茨海默病诊断剂。
  • NOVEL COMPOUND HAVING AFFINITY TO AMYLOID
    申请人:NIHON MEDI-PHYSICS CO., LTD.
    公开号:EP2022792B1
    公开(公告)日:2010-12-29
  • US8022207B2
    申请人:——
    公开号:US8022207B2
    公开(公告)日:2011-09-20
查看更多